Showing results (211-220 of 224) with videos related to

Sort By:
Pageof 23
Plos One|September 17, 2013
Multicenter intestinal current measurements in rectal biopsies from CF and non-CF subjects to monitor CFTR functionJohn P Clancy, Rhonda D Szczesniak, Melissa A Ashlock, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 23, 2021
PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapyDave P Nichols, Scott H Donaldson, Carla A Frederick, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 24, 2022
Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GISarah Jane Schwarzenberg, Phuong T Vu, Michelle Skalland, et al.
The Journal of Chemical Physics|October 19, 2010
Investigation of antirelaxation coatings for alkali-metal vapor cells using surface science techniquesS J Seltzer, D J Michalak, M H Donaldson, et al.
American Journal of Respiratory and Critical Care Medicine|November 16, 2021
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical TrialDavid P Nichols, Alex C Paynter, Sonya L Heltshe, et al.
American Journal of Respiratory and Critical Care Medicine|November 26, 2019
Airway Mucus Hyperconcentration in Non-Cystic Fibrosis BronchiectasisKathryn A Ramsey, Alice C H Chen, Giorgia Radicioni, et al.
The Lancet. Respiratory Medicine|September 12, 2023
Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspectiveNicole Mayer-Hamblett, John Paul Clancy, Raksha Jain, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinasesEdgar R Wood, Lisa M Shewchuk, Byron Ellis, et al.
Pageof 23